Home > Insider Trading > Filing (0001179110-17-013895)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1624658	Allena Pharmaceuticals Inc.	ALNA	Biological Products, (No Disgnostic Substances) (2836)	452729920

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1721496	Hbm Biocapital Ii Lp	11-15 Seaton Place St.helier Y9 JE4 0QH		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-11-06	1,426,061	$0.00	1,426,061	No	4	C	Direct
Common Stock	Acquisiton	2017-11-06	140,841	$0.00	1,566,902	No	4	C	Direct
Common Stock	Acquisiton	2017-11-06	71,428	$14.00	1,638,330	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2017-11-06	5,952,380	$0.00	1,426,061	$0.00
Common Stock	Series C Preferred Stock	Disposition	2017-11-06	587,872	$0.00	140,841	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Issued upon conversion of Series Series B Preferred Stock upon closing of Issuer's initial public offering.
Issued upon conversion of Series Series C Preferred Stock upon closing of Issuer's initial public offering.
Each share of the Issuer's Series B and Series C Preferred Stock automatically converted into one share of the Issuer's Common Stock on a 4.174-to-1 basis upon the closing of the Issuer's initial public offering and has no expiration date.